Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Seminars in Hematology|June 5, 2024
Lessons learned from the Eµ-TCL1 mouse model of CLLAlessia Floerchinger, Martina SeiffertHemasphere|February 27, 2023
Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic LeukemiaSebastian Faehling, Mariana Coelho, Alessia Floerchinger, et al.Methods in Molecular Biology (Clifton, N.J.)|June 22, 2022
NK Cell Effector Functions and Bystander Tumor Cell Killing in ImmunovirotherapyAlessia Floerchinger, Christine E EngelandClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2020
Antibody Peptides as Cancer Vaccine-Turning Weapons to TargetsMartina SeiffertLeukemia|May 28, 2020
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?Philipp M Roessner, Martina SeiffertBlood|May 28, 2024
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo modelsBerit J Brinkmann, Alessia Floerchinger, Christina Schniederjohann, et al.Molecular Immunology|November 28, 2017
Beyond bystanders: Myeloid cells in chronic lymphocytic leukemiaBola S Hanna, Selcen Öztürk, Martina SeiffertScientific Reports|July 14, 2018
Autoantigen-Harboring Apoptotic Cells Hijack the Coinhibitory Pathway of T Cell ActivationAbraam M Yakoub, Ralph Schulz, Martina Seiffert, et al.Cancers|April 30, 2021
IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic LeukemiaSelcen Öztürk, Verena Kalter, Philipp M Roessner, et al.Haematologica|December 8, 2010
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Angela Schulz, Grischa Toedt, Thorsten Zenz, et al.Pageof 7